Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Thornadtsson (Gävle, Sweden), A. Malinovschi (Uppsala, Sweden), K. Bröms (Gävle, Sweden), C. Janson (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), H. Hedenström (Uppsala, Sweden), M. Högman (Uppsala, Sweden). Ex-smokers with frequent COPD exacerbations have low FENO in stable condition. 2616

Member's Comments

No comment yet.

Related content which might interest you: Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function Year: 2013 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Frequent COPD exacerbators are not a stabile phenotype Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006 Polution the real culprit for asthma and COPD exacerbations Source: Year: 2008 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy? Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 frequent exacerbations of COPD are associated with severity of airflow limitation and chronic cough, sputum production. Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 COPD exacerbations and predictors in a general population Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Budesonide/formoterol significantly improves lung function and reduces exacerbations in both smokers and ex-smokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006 Formoterol given either alone or together with tiotropium, reduces the rate of exacerbations in stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006 The clinical significance and frequency of bronchiectasis in COPD patients Source: International Congress 2016 – Monitoring comorbidities Year: 2016 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013 Cough in exacerbations of COPD Source: Annual Congress 2008 - COPD: from bench to bedside Year: 2008 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 Midrange-proadrenomedullin in stable state predicts severe exacerbation of COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Comparison of COPD patients with high and low symptoms from a real-world US survey Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015